Latest filing published 17 Apr 2026 for MapLight Therapeutics, Inc., €196k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Robert C. Malenka: trading record in brief
Robert C. Malenka is a declared insider of MapLight Therapeutics, Inc., with filings sourced from SEC (Form 4). We count 16 filings; the first trade dates from 27 October 2025 and the latest from 15 April 2026.
Sales make up the whole of the open-market record (14 sales, €1.3M). Besides market trades, the filings include 1 share grant. Since January 2026: no purchases and 14 sales on the market.
The latest filing, published on 17 April 2026, reports an open-market sale of €196k in MapLight Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Robert C. Malenka
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,593 shares@ US$26.900.014% mcap100.0% of flowVoting Common StockSEC:0002021198-26-000013:0
- 34,390 shares0Voting Common StockSEC:0002021198-25-000006:0
2 of 2 declarations